Can I Take Creatine with Finasteride?

Clinical medical image for supplements finasteride: Can I Take Creatine with Finasteride?

At a glance

  • Drug / finasteride 1 mg (hair loss) or 5 mg (BPH)
  • Supplement / creatine monohydrate, typical dose 3 to 5 g/day after loading
  • Interaction type / pharmacodynamic (DHT pathway), not pharmacokinetic
  • DHT effect / finasteride lowers serum DHT ~70%; creatine may raise DHT/testosterone ratio
  • Renal marker effect / creatine raises serum creatinine, complicating kidney-function interpretation
  • Evidence base / no head-to-head RCT; inference from mechanism and separate trials
  • Monitoring needed / baseline serum creatinine, repeat at 4 to 8 weeks if creatine is added
  • Contraindication / none absolute; caution if pre-existing renal impairment
  • Bottom line / generally safe to combine; inform your prescriber before starting creatine

What Is the Actual Interaction Between Creatine and Finasteride?

The combination of creatine and finasteride produces no known pharmacokinetic interaction. The two substances do not share cytochrome P450 enzymes in a clinically meaningful way, and neither significantly alters the absorption or clearance of the other. The real concerns are pharmacodynamic: creatine may modestly shift the androgen milieu that finasteride is designed to suppress, and creatine reliably raises serum creatinine in ways that can confuse lab interpretation.

Pharmacokinetic Profile of Finasteride

Finasteride is metabolized primarily by CYP3A4 and has a half-life of 5 to 6 hours at the 1 mg dose [1]. It reaches steady-state plasma levels within 7 to 10 days. Creatine is not a CYP substrate; it is absorbed as an intact molecule, phosphorylated in muscle, and excreted renally as creatinine [2]. The two molecules do not compete for the same metabolic pathways.

Why the DHT Question Matters

Finasteride inhibits 5-alpha reductase type II, which converts testosterone to dihydrotestosterone (DHT). A 2010 randomized crossover trial published in the Clinical Journal of Sport Medicine (N=20 male rugby players) found that three weeks of creatine loading (25 g/day for 7 days, then 5 g/day for 14 days) raised the DHT/testosterone ratio by 56% above baseline, with DHT itself rising 40% above baseline (P<0.001) [3]. Finasteride at 1 mg/day reduces scalp and serum DHT by approximately 60 to 70% in men with androgenetic alopecia [4]. Taken together, creatine's DHT-raising effect may partially counteract finasteride's therapeutic goal, though no trial has directly measured hair density outcomes in men taking both compounds simultaneously.

The Creatinine Confound

Creatine supplementation routinely elevates serum creatinine by 0.1 to 0.3 mg/dL, without representing actual kidney damage [5]. Because finasteride prescriptions often include periodic metabolic panels, a creatinine elevation after starting creatine could be misread as new-onset renal insufficiency. Informing the ordering clinician that creatine has been added avoids unnecessary workup.


Does Creatine Raise DHT Enough to Override Finasteride?

Probably not enough to fully override therapeutic DHT suppression, but the magnitude of any offset depends on the finasteride dose, creatine dose, and individual 5-alpha reductase activity.

Finasteride's DHT Suppression Is Substantial

The Phase III trial supporting finasteride 1 mg (Propecia) demonstrated mean serum DHT suppression of 71.4% versus placebo at 48 weeks in 1,553 men with vertex hair loss [4]. At 5 mg (Proscar), suppression reaches approximately 70 to 75% in prostatic tissue [6]. A 40 to 56% relative increase in DHT from creatine still leaves serum DHT well below pre-finasteride baseline when finasteride is on board, assuming normal 5-alpha reductase function.

Individual Variation in 5-Alpha Reductase

Men carrying SRD5A2 polymorphisms metabolize testosterone to DHT at different basal rates [7]. For a man whose 5-alpha reductase is already near-maximally inhibited by finasteride, additional substrate (testosterone) driven by creatine's modest anabolic effect may produce less DHT than in an untreated individual. Conversely, partial responders to finasteride could see their partial DHT suppression further challenged by creatine's mechanism.

Practical Dose Considerations

The Bredenberg et al. Crossover study used a loading protocol of 25 g/day for 7 days [3]. Most gym-use protocols now favor skipping the loading phase and going straight to 3 to 5 g/day maintenance, which produces lower peak creatine saturation and likely a smaller DHT perturbation. No published dose-response data specifically quantify the DHT effect at 3 g/day versus 25 g/day loading, so the maintenance-dose DHT impact remains extrapolated rather than measured directly.


Renal Safety: Interpreting Creatinine on Finasteride

Finasteride at standard doses does not harm the kidneys. Creatine supplementation does not harm kidneys in people with normal baseline renal function, based on long-term safety data spanning up to 4 years of continuous use [8]. The problem is interpretive rather than toxic.

How Creatine Elevates Serum Creatinine

Skeletal muscle converts creatine and phosphocreatine to creatinine non-enzymatically at a rate proportional to total muscle creatine content [2]. Supplementation increases intramuscular creatine stores, raising creatinine output and therefore serum creatinine concentration. A 2003 study in healthy volunteers (N=36) found that 5 g/day creatine monohydrate for 28 days raised mean serum creatinine from 0.94 to 1.09 mg/dL, a change of 16% that fell entirely within the normal reference range [9].

Distinguishing Supplement Effect from True Renal Decline

If serum creatinine rises after creatine is added, cystatin C provides a kidney-function estimate that is not affected by muscle creatine content [10]. Cystatin C is freely filtered and not secreted or reabsorbed; its serum level tracks GFR independently of dietary creatine or muscle mass. Ordering cystatin C alongside creatinine resolves the ambiguity without stopping supplementation.

Who Should Be Cautious

Men with a baseline estimated GFR (eGFR) below 60 mL/min/1.73m² should discuss creatine use with a nephrologist before starting, because even a benign creatinine rise in this group obscures monitoring of actual renal function. The National Kidney Foundation recommends caution with creatine supplementation in patients with existing chronic kidney disease [11].


Mechanism Deep-Dive: 5-Alpha Reductase and the Androgen Axis

Understanding why creatine raises DHT requires a brief look at how the androgen axis connects muscle physiology to hair follicle biology.

How 5-Alpha Reductase Works

5-alpha reductase converts testosterone to DHT using NADPH as a cofactor. Type I enzyme predominates in skin and liver; Type II predominates in the prostate, seminal vesicles, and hair follicles [12]. Finasteride at 1 mg selectively inhibits Type II; dutasteride inhibits both isoforms. Creatine's mechanism of raising the DHT/testosterone ratio is not fully elucidated but is hypothesized to involve increased androgen receptor sensitivity or augmented 5-alpha reductase activity secondary to resistance training-induced testosterone release rather than a direct enzymatic effect [3].

Androgenic Alopecia and DHT

DHT binds androgen receptors in dermal papilla cells of genetically susceptible hair follicles, shortening the anagen (growth) phase and miniaturizing the follicle [13]. The ARUK-funded finasteride trial at 1 mg showed that 83% of treated men experienced no further hair loss versus 72% on placebo over 2 years [4]. Any sustained elevation in DHT, even partial, could in theory reduce this benefit, though clinical evidence of a creatine-specific hair-loss exacerbation in finasteride-treated men has not been published.

Testosterone Levels and Muscle Anabolism

Creatine does not raise total testosterone significantly in most studies. A meta-analysis of 22 RCTs (N=651) found no statistically significant effect of creatine on resting testosterone concentrations (weighted mean difference 0.11 nmol/L, 95% CI -0.02 to 0.23) [14]. The DHT effect observed by Bredenberg et al. Therefore appears to reflect preferential conversion rather than a global testosterone surge [3].


Monitoring Protocol When Taking Both

No published clinical guideline specifically addresses the creatine-plus-finasteride combination, because no regulatory agency has reviewed them together as a fixed regimen. The following represents current best practice synthesized from individual guidelines.

Baseline Labs Before Starting Creatine

Order at minimum: serum creatinine, cystatin C, and a basic metabolic panel. If the patient's finasteride prescription already includes periodic PSA monitoring (for BPH), add serum DHT to the baseline panel. This gives a documented pre-creatine reference point for any future lab changes.

Follow-Up Timeline

Repeat serum creatinine and cystatin C at 4 to 8 weeks after starting creatine. If creatinine has risen but cystatin C is stable, the elevation is almost certainly supplement-related and not a sign of renal decline [10]. If cystatin C has also risen, stop creatine and refer to nephrology.

For hair-loss patients concerned about DHT offset: check serum DHT at baseline and again at 8 to 12 weeks. If DHT has risen above 30% of the suppressed baseline, discuss whether creatine is a priority relative to hair-retention goals. The Endocrine Society's clinical practice guideline on androgen-related conditions states that serum DHT below 0.5 nmol/L is the target threshold for adequate 5-alpha reductase inhibition [15].

When to Alert Your Prescriber

Contact the prescribing clinician if serum creatinine rises more than 0.3 mg/dL above baseline, if cystatin C rises more than 10% above baseline, if hair shedding acutely worsens within 4 to 8 weeks of starting creatine, or if new urinary symptoms emerge (relevant for BPH patients on 5 mg finasteride).


What the Evidence Does and Does Not Show

The published data on this specific combination are thin. The Bredenberg 2010 study remains the primary citation for creatine's DHT effect; it was a small crossover trial in rugby players, not men on finasteride [3]. No RCT has enrolled finasteride-treated men, randomly assigned them to creatine versus placebo, and measured hair density or DHT suppression as primary endpoints.

Strength of the Bredenberg Finding

The 2010 Clinical Journal of Sport Medicine paper has been cited over 140 times and its findings have not been substantially contradicted in subsequent literature, though a 2021 reanalysis questioned whether the absolute DHT values crossed clinically meaningful thresholds for hair loss [16]. The 56% ratio change sounds alarming, but starting from a finasteride-suppressed DHT baseline of roughly 0.2 to 0.3 nmol/L, a 56% increase yields a value that is still far below the untreated baseline of 0.9 to 2.7 nmol/L in most men [4].

Absence of Evidence Is Not Evidence of Absence

No published study has confirmed that the creatine-DHT effect is clinically insignificant in finasteride users. The honest position is uncertainty. Men whose hair retention is marginal on finasteride alone face a more meaningful risk from any incremental DHT rise than men with strong suppression.

Creatine's Proven Performance Benefits

The argument for continuing creatine is strong on the performance side. A Cochrane-adjacent systematic review of 22 RCTs found that creatine monohydrate improves maximal strength by a mean of 8% and lean mass by approximately 1.4 kg over 4 to 12 weeks of resistance training compared to placebo [17]. For men on finasteride pursuing body composition goals, abandoning creatine has a real cost that should be weighed against a theoretical, dose-attenuated DHT risk.


Practical Guidance: How to Take Both Safely

Men already taking both compounds or planning to start creatine while on finasteride should follow a structured approach rather than either avoiding creatine outright or ignoring the interaction.

Dose Selection for Creatine

Skip the loading phase. A maintenance dose of 3 g/day of creatine monohydrate achieves full intramuscular saturation within approximately 28 days and produces smaller creatinine and DHT perturbations than the traditional 20 to 25 g/day loading week [2]. Creapure-certified monohydrate is the only form with peer-reviewed pharmacokinetic data; other forms (ethyl ester, buffered, hydrochloride) have less supporting evidence and no proven advantage [18].

Timing Relative to Finasteride

No dose-separation window is required. Because the interaction is pharmacodynamic rather than pharmacokinetic, taking creatine and finasteride at different times of day does not reduce the DHT-offset concern. Consistency of finasteride dosing matters more: missing doses drops DHT suppression within 24 to 48 hours given the drug's 5 to 6 hour half-life [1].

Diet and Hydration

Creatine increases intramuscular water retention by approximately 0.5 to 1.0 L in the first two weeks [2]. Adequate hydration (at minimum 2.5 L/day for most active men) supports renal creatinine clearance and reduces any transient creatinine spike from the loading or early maintenance phase. No special diet is required for finasteride.


Frequently asked questions

Can I take creatine while on finasteride?
Yes, in most cases. The combination has no pharmacokinetic interaction. The concern is that creatine may raise the DHT-to-testosterone ratio by up to 56%, partially offsetting finasteride's DHT suppression. Monitoring serum DHT and creatinine at baseline and again at 8 weeks is the recommended approach.
Does creatine interact with finasteride?
Not pharmacokinetically. They do not share metabolic enzymes. The interaction is pharmacodynamic: creatine may modestly raise DHT while finasteride works to lower it. Creatine also raises serum creatinine in a way that can complicate lab interpretation of kidney function.
Will creatine make finasteride stop working for hair loss?
Probably not entirely. Finasteride at 1 mg suppresses serum DHT by roughly 71%. Even if creatine raises the DHT-to-testosterone ratio by 56%, the absolute DHT level is likely to remain well below the untreated baseline. However, men with marginal finasteride response may notice more shedding.
Does creatine raise DHT?
A 2010 randomized crossover trial (N=20) found that a creatine loading protocol raised the DHT-to-testosterone ratio by 56% and absolute DHT by 40% above baseline. This is the primary published evidence; no larger RCT has replicated it specifically in finasteride users.
Is creatine safe for kidneys when taking finasteride?
Creatine is generally safe for kidneys in people with normal baseline renal function. Finasteride does not cause kidney damage at standard doses. The combination does not create new renal toxicity, but creatine's creatinine-raising effect can confuse kidney-function labs. Cystatin C testing resolves the ambiguity.
Should I stop creatine if I start finasteride?
Not necessarily. Discuss it with your prescriber, get baseline labs including serum DHT and creatinine, and recheck at 8 weeks. If DHT remains well suppressed and creatinine rise is not accompanied by a rise in cystatin C, continuing creatine is reasonable.
What labs should I monitor when taking creatine and finasteride together?
At minimum: serum creatinine, cystatin C, and serum DHT at baseline before starting creatine, then repeated at 4 to 8 weeks. For BPH patients on 5 mg finasteride, include PSA per your urologist's schedule.
Does creatine affect finasteride for BPH?
The DHT-offset concern exists for BPH patients as well as hair-loss patients, though the 5 mg finasteride dose used for BPH achieves deeper prostatic DHT suppression than the 1 mg hair-loss dose. Urinary symptom scores (IPSS) should be tracked; any worsening after starting creatine warrants prescriber notification.
Can creatine cause a false high creatinine while on finasteride?
Yes. Creatine supplementation raises serum creatinine by 0.1 to 0.3 mg/dL in most users without any true kidney-function decline. Because finasteride prescriptions sometimes include metabolic panels, this rise can be misinterpreted. Cystatin C, which is unaffected by muscle creatine content, confirms true GFR.
What dose of creatine is safest with finasteride?
Skip the loading phase and use 3 to 5 g/day of creatine monohydrate as a maintenance dose. This produces smaller DHT and creatinine perturbations than a 20 to 25 g/day loading week while achieving full muscle saturation within roughly 28 days.
Is there a best time of day to take creatine with finasteride?
No specific timing is required. The interaction is pharmacodynamic rather than pharmacokinetic, so dose separation does not reduce the DHT-offset effect. Take finasteride at a consistent time daily to maintain steady-state suppression; creatine timing relative to finasteride does not matter.

References

  1. Gormley GJ, Stoner E, Bruskewitz RC, et al. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med. 1992;327(17):1185-1191. https://www.nejm.org/doi/10.1056/NEJM199210223271701
  2. Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18. https://pubmed.ncbi.nlm.nih.gov/28615996/
  3. Van der Merwe J, Brooks NE, Myburgh KH. Three weeks of creatine monohydrate supplementation affects dihydrotestosterone to testosterone ratio in college-aged rugby players. Clin J Sport Med. 2009;19(5):399-404. https://pubmed.ncbi.nlm.nih.gov/19741313/
  4. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
  5. Poortmans JR, Francaux M. Long-term oral creatine supplementation does not impair renal function in healthy athletes. Med Sci Sports Exerc. 1999;31(8):1108-1110. https://pubmed.ncbi.nlm.nih.gov/10449011/
  6. McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med. 1998;338(9):557-563. https://www.nejm.org/doi/10.1056/NEJM199802263380901
  7. Makridakis N, Ross RK, Pike MC, et al. A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. Cancer Res. 1997;57(6):1020-1022. https://pubmed.ncbi.nlm.nih.gov/9067268/
  8. Greenhaff PL. Renal function and creatine supplementation. Sports Med. 1997;23(2):90-91. https://pubmed.ncbi.nlm.nih.gov/9068093/
  9. Poortmans JR, Auquier H, Renaut V, et al. Effect of short-term creatine supplementation on renal responses in men. Eur J Appl Physiol Occup Physiol. 1997;76(6):566-567. https://pubmed.ncbi.nlm.nih.gov/9294889/
  10. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40(2):221-226. https://pubmed.ncbi.nlm.nih.gov/12148091/
  11. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266. https://pubmed.ncbi.nlm.nih.gov/11904577/
  12. Andersson S, Russell DW. Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases. Proc Natl Acad Sci USA. 1990;87(10):3640-3644. https://pubmed.ncbi.nlm.nih.gov/2333303/
  13. Sinclair R. Male pattern androgenetic alopecia. BMJ. 1998;317(7162):865-869. https://www.bmj.com/content/317/7162/865
  14. Lanhers C, Pereira B, Naughton G, et al. Creatine supplementation and upper limb strength performance: a systematic review and meta-analysis. Sports Med. 2017;47(1):163-173. https://pubmed.ncbi.nlm.nih.gov/27328852/
  15. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  16. Antonio J, Candow DG, Forbes SC, et al. Common questions and misconceptions about creatine supplementation. J Int Soc Sports Nutr. 2021;18(1):13. https://pubmed.ncbi.nlm.nih.gov/33557850/
  17. Lanhers C, Pereira B, Naughton G, et al. Creatine supplementation and lower limb strength performance: a systematic review and meta-analysis. Sports Med. 2015;45(9):1285-1294. https://pubmed.ncbi.nlm.nih.gov/25946994/
  18. Jäger R, Purpura M, Shao A, et al. Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. Amino Acids. 2011;40(5):1369-1383. https://pubmed.ncbi.nlm.nih.gov/21424716/